Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.
SMI 10'482 1.9%  SPI 13'428 1.8%  Dow 29'491 2.7%  DAX 12'505 2.4%  Euro 0.9757 0.1%  EStoxx50 3'433 2.7%  Gold 1'708 0.5%  Bitcoin 19'645 0.9%  Dollar 0.9890 -0.3%  Öl 89.3 0.7% 

<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Strukturierte Produkte
>
09.08.2022 21:25:04

Why BioNTech Was Tumbling Again Today

This isn't shaping up to be a banner week for BioNTech (NASDAQ: BNTX). The bellwether coronavirus stock took it on the chin Monday and was being similarly battered by investors Tuesday because of post-earnings analyst price target cuts. As of midafternoon trading, the biotech's shares had lost more than 7% of their value.Following second-quarter results that disappointed many investors, several analysts recalibrated their takes on BioNTech stock Tuesday. One was Goldman Sachs' Chris Shibutani, who cut his price target on the shares to $200 apiece from his former level of $209. He's maintaining his neutral recommendation on the stock, however.Another cutter was Berenberg's Shanshan Xu, with a chop from $350 per share to $312. Xu's recommendation, a buy, is also being maintained.Continue reading
Weiter zum vollständigen Artikel bei "MotleyFool"

INFLATION: WELTWEIT STEIGEN DIE PREISE

Viele Anleger setzen deshalb auf den Aktiv verwalteten Global Inflation Protection Basket. Informieren Sie sich über die breit gestreute Auswahl an robusten Aktien & ETFs.